AUDREY PIKA: Open Payments
NPI 1922626225 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 34 payments from 11 companies in 2025. Trend: 2023 $1,329 · 2024 $1,490 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $265 |
| Paratek Pharmaceuticals, Inc. | 8 | $209 |
| Axsome Therapeutics, Inc. | 4 | $181 |
| CeQur Corporation | 1 | $123 |
| ABBVIE INC. | 5 | $82 |
| Lilly USA, LLC | 3 | $48 |
| Optinose US, Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $16 |
Products named: AIRSUPRA, NUZYRA, Symbravo, CeQur Simplicity, UBRELVY, Xhance, SYNTHROID, FARXIGA.
Industry payments across TX — which companies pay providers there.
